From the authors

European Respiratory Journal

Volumn 46, Issue 6, 2015, Pages 1851-1853

  Savale, Laurent ^a,b   Chaumais, Marie Camille ^b,c,d   Sitbon, Olivier ^a,b,c   Humbert, Marc ^a,b,c  

^a BICÊTRE HOSPITAL   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; IMMUNOLOGIC FACTOR;

FEMALE; HUMAN; HYPERTENSION, PULMONARY; MALE;

ANTIVIRAL AGENTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; INTERFERON-BETA; MALE;

EID: 84948961015     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.01376-2015     Document Type: Letter

References (13)

1. Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: Suppl., D34-D41.
2. Fruehauf S, Steiger S, Topaly J, et al. Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia. Ann Hematol 2001; 80: 308-310.
3. Jochmann N, Kiecker F, Borges AC, et al. Long-term therapy of interferon-α induced pulmonary arterial hypertension with different PDE-5 inhibitors: a case report. Cardiovasc Ultrasound 2005; 3: 26.
4. Ledinek AH, Jazbec SS, Drinovec I, et al. Pulmonary arterial hypertension associated with interferon β treatment for multiple sclerosis: a case report. Mult Scler 2009; 15: 885-886.
5. Dhillon S, Kaker A, Dosanjh A, et al. Irreversible pulmonary hypertension associated with the use of interferon α for chronic hepatitis C. Dig Dis Sci 2010; 55: 1785-1790.
6. Caravita S, Secchi MB, Wu SC, et al. Sildenafil therapy for interferon-β-1a-induced pulmonary arterial hypertension: a case report. Cardiology 2011; 120: 187-189.
7. McGovern EM, Judge EP, Kavanagh E, et al. Interferon β related pulmonary arterial hypertension; an emerging worrying entity? Mult Scler Relat Disord 2015; 4: 284-286.
8. Gibbons E, Promislow S, Davies RA, et al. Reversible pulmonary arterial hypertension associated with interferon-β treatment for multiple sclerosis. Can Respir J 2015; 22: 263-265.
9. Ko T, Hatano M, Nitta D, et al. A case of interferon-alpha-induced pulmonary arterial hypertension after living donor liver transplantation. Heart Vessels 2015 [in press; DOI: 10.1007/s00380-015-0701-1].
10. Anderson RD, Thompson A, Burns AT. Pulmonary arterial hypertension associated with the use of interferon therapy for chronic hepatitis C infection complicated by extrinsic left main coronary artery compression. Intern Med J 2014; 44: 1027-1030.
11. Savale L, Sattler C, Günther S, et al. Pulmonary arterial hypertension in patients treated with interferon. Eur Respir J 2014; 44: 1627-1634.
12. George PM, Oliver E, Dorfmuller P, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension. Circ Res 2014; 114: 677-688.
13. Seferian A, Chaumais MC, Savale L, et al. Drugs induced pulmonary arterial hypertension. Presse Med 2013; 42: e303-e310.